Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension
Completed
Takeda
Phase 2
2006-05-01
The purpose of this study is to evaluate the safety, efficacy, and tolerability of azilsartan
medoxomil, once daily (QD), in individuals with hypertension.
Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension
Completed
Takeda
Phase 3
2007-10-01
The purpose of this study is to evaluate the effectiveness and safety of azilsartan medoxomil
compared to placebo, once daily (QD), in African-American participants with essential
hypertension.
Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension
Completed
Takeda
Phase 3
2007-10-01
The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil,
once daily (QD), co-administered with amlodipine in treating individuals with essential
hypertension, compared to treatment with amlodipine alone.
Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
Completed
Takeda
Phase 3
2007-12-01
The purpose of this study is to compare the efficacy and safety of TAK-491 (azilsartan
medoxomil), once daily (QD), to valsartan in participants with essential hypertension.
Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
Completed
Takeda
Phase 3
2007-09-01
The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil,
once daily (QD), co-administered with chlorthalidone in treating individuals with essential
hypertension, compared to treatment with chlorthalidone alone.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
